Simpson Emmanuel News Today

India Business News: Despite a tendency of lower exposure and slow performance among most pharmaceutical MNCs in India, Swiss biotech behemoth Roche is defying the trend.

Indias pharma sector on Wednesday said the Goods and Services Tax (GST) Councils decision to exempt tax on rare diseases drugs is unlikely to benefit the population unless the waiver is extended to drugs that are made commercially available in the country. The GST Council on Tuesday (July 11) said the Integrated Goods and Services Tax (IGST) on medicines and Food for Special Medical Purposes (FSMP) used for treating rare diseases enlisted under the National Policy for Rare Diseases, 2021, will b...

PINK Project initiative to help address gaps in breast cancer treatment launched in Punjab

Last Updated: All About Roches COVID Antibody Cocktail That India Approved As Treatment For Mild Cases A Switzerland based drug maker, Roche has received approval from Indias Central Drugs Standards Control Organisation (CDSCO) for COVID-19 emergency use . Image: PTI Widening the arsenal of drugs to combat COVID-19, a Switzerland-based drug maker, Roche has received approval from Indias Central Drugs Standards Control Organisation (CDSCO) for use in emergency situations for treatment of C...

Last Updated: India Approves Roches Antibody Cocktail COVID Treatment For Mild Cases; Trump Had Taken The Central Drugs Standards Control Organisation (CDSCO) on Wednesday granted Emergency Use Authorisation (EUA) to Roche for the antibody cocktail. Expanding its arsenal of drugs to battle the massive second wave of COVID-19, the Central Drugs Standards Control Organisation (CDSCO) on Wednesday granted Emergency Use Authorisation (EUA) to Swiss pharma company Roche for the antibody c...

Cipla MD and Global CEO Umang Vohra said, This partnership with Roche is a significant step in enabling access to promising treatments in furtherance to our purpose of Caring for Life.

Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatment SECTIONS Last Updated: May 05, 2021, 08:04 PM IST Share Synopsis The antibody cocktail is to be administered for the treatment of mild to moderate coronavirus disease in adults and pediatric patients (12 years of age or older, weighing at least 40 kg) who are confirmed to be infected with SARS-COV2 and who are at high risk of developing severe COVID-19 disease, the statement said. PTI Drug firm Roche India ...